Semaglutide in heart failure with preserved or mildly reduced ejection fraction
Posted 17 Apr 2025
Dr Lisa Devine discusses the findings of a post-hoc pooled analysis of four randomised placebo-controlled trials examining the effects of semaglutide on heart failure events and cardiovascular death.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page